Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 442)
Posted On: 02/26/2021 1:35:14 PM
Post# of 72448
Posted By: petemantx
Trial admin are walking a very fine line in this trial IMO in regards to patients getting the SOC only.

By day 2 or 3 (at the latest) I would expect they see the SOC +B patients are severely decreasing their viral load and, in addition, they should be starting to see quite improved breathing and lung functioning.

But the SOC only patients will be pretty much static in their improvement since R does not seem to affect the viral load nor do much for the lungs; if so the mortality rate would have dropped and it has not to date.

So at what point do you add B to the SOC only patients - at what point are their lives in danger of the symptoms getting too bad and lung stem cells damaged that B can't even help the problem?

They only gave Rems about a day or two when Trump went to Walter Reed before they also gave him the Regeneron antibody treatment.














(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site